Literature DB >> 6489486

Lysozyme and lactoferrin in sputum from patients with chronic obstructive lung disease.

O Harbitz, A O Jenssen, O Smidsrød.   

Abstract

The two basic proteins lysozyme and lactoferrin have been isolated from solubilized mucoid sputum from patients with chronic bronchitis in one step by cation exchange chromatography. In sputa from 13 patients with chronic bronchitis their mean concentrations were 0.4 g/l and 0.7 g/l, respectively, representing 6.6% and 11.5% of the total amount of solubilized protein. Lysozyme and the acid mucin glycoproteins of sputum formed aggregates at low ionic strength, probably as a result of electrostatic interactions between the two. Although only aggregates were formed and not a viscoelastic fluid or a gel, these interactions may contribute to the viscoelastic properties of native sputum.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489486

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  13 in total

Review 1.  Antimicrobial polypeptides in host defense of the respiratory tract.

Authors:  Tomas Ganz
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 2.  Hidden risks for pneumonia in Malawi.

Authors:  D G Fullerton; S B Gordon
Journal:  Malawi Med J       Date:  2003-06       Impact factor: 0.875

Review 3.  Physicochemical properties of mucus and their impact on transmucosal drug delivery.

Authors:  Jasmim Leal; Hugh D C Smyth; Debadyuti Ghosh
Journal:  Int J Pharm       Date:  2017-09-14       Impact factor: 5.875

4.  Antibiotic tolerance induced by lactoferrin in clinical Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  María T Andrés; Mónica Viejo-Diaz; Francisco Pérez; José F Fierro
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

5.  Interaction between secretory leucocyte proteinase inhibitor and bronchial mucins or glycopeptides. Physiopathological implications for the protection of mucins against proteolysis by human leucocyte elastase.

Authors:  I Van-Seuningen; J P Aubert; M Davril
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

6.  A possible role for lysozyme in determining acute exacerbation in chronic bronchitis.

Authors:  D C Taylor; A W Cripps; R L Clancy
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

7.  The host defense peptide beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets.

Authors:  Shokrollah Elahi; Rachelle M Buchanan; Sam Attah-Poku; Hugh G G Townsend; Lorne A Babiuk; Volker Gerdts
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

8.  Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions.

Authors:  G D Raphael; E V Jeney; J N Baraniuk; I Kim; S D Meredith; M A Kaliner
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

9.  Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells.

Authors:  Sophie Moreau-Marquis; George A O'Toole; Bruce A Stanton
Journal:  Am J Respir Cell Mol Biol       Date:  2009-01-23       Impact factor: 6.914

Review 10.  Micro- and macrorheology of mucus.

Authors:  Samuel K Lai; Ying-Ying Wang; Denis Wirtz; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2009-01-03       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.